October 28, 2022
October 28, 2022 —
In animal models, UC San Diego researchers found that intensive physical therapy in tandem with implanted neural stem cells increased tissue growth, repair and functionality in spinal cord injuries more than those treatments alone.
October 27, 2022
October 27, 2022 —
UC San Diego will be one of multiple sites assessing the safety and efficacy of tecovirimat as a potential treatment for human monkeypox. Marketed as TPOXX, tecovirimat is an antiviral currently approved for treatment of human smallpox in adults and children caused by the variola virus.
October 26, 2022
October 26, 2022 —
Researchers at UC San Diego have identified a new signaling process involving G protein-coupled receptors (GPCRs), a cellular target already exploited by hundreds of diverse drugs. The discovery opens the possibility of new therapies, including for multiple forms of cancer.
October 25, 2022
October 25, 2022 —
Building upon a long history, the UC San Diego has launched a new Human Milk Institute to accelerate research into the biology and therapeutic potential of human milk to prevent or treat both infant and adult diseases. The new institute is believed to be the first of its kind in the United States.
October 24, 2022
October 24, 2022 —
Using a novel systems biology approach, scientists at UC San Diego School of Medicine have further parsed the cellular players and roles involved in rheumatoid arthritis, a complex disease that affects more than one million Americans in ways that have defied development of uniform treatments.
October 18, 2022
October 18, 2022 —
Victor Nizet, MD, Distinguished Professor of Pediatrics at University of California San Diego School of Medicine and Pharmacy at Skaggs School of Pharmacy and Pharmaceutical Sciences, has been elected to the National Academy of Medicine.
October 11, 2022
October 11, 2022 —
UC San Diego scientists are leading a national early-stage clinical trial to assess the safety and efficacy of using bacteriophages to treat drug-resistant bacterial infections in cystic fibrosis patients.
October 5, 2022
October 5, 2022 —
UC San Diego researchers discover that quality and mix of protein in a type of pancreatic cancer is the determinant of whether the prognosis is poor or very poor.
September 29, 2022
September 29, 2022 —
An international team of scientists, co-led by researchers at the University of California San Diego School of Medicine, has created the first pan-cancer mycobiome atlas—a survey of 35 types of cancer and their associated fungi.
September 26, 2022
September 26, 2022 —
In the first known study of its type, an international team of researchers evaluated whether high research and development costs explain high drug prices in the United States. They found no such association for 60 new drugs approved from 2009 to 2018.
